Signaling Pathways Involved in Myocardial Ischemia-Reperfusion Injury and Cardioprotection: A Systematic Review of Transcriptomic Studies in Sus scrofa
- PMID: 35621843
- PMCID: PMC9145716
- DOI: 10.3390/jcdd9050132
Signaling Pathways Involved in Myocardial Ischemia-Reperfusion Injury and Cardioprotection: A Systematic Review of Transcriptomic Studies in Sus scrofa
Abstract
Myocardial damage in acute myocardial infarctions (AMI) is primarily the result of ischemia−reperfusion injury (IRI). Recognizing the timing of transcriptional events and their modulation by cardioprotective strategies is critical to address the pathophysiology of myocardial IRI. Despite the relevance of pigs for translational studies of AMI, only a few have identified how transcriptomic changes shape cellular signaling pathways in response to injury. We systematically reviewed transcriptomic studies of myocardial IRI and cardioprotection in Sus scrofa. Gene expression datasets were analyzed for significantly enriched terms using the Enrichr analysis tool, and statistically significant results (adjusted p-values of <0.05) for Signaling Pathways, Transcription Factors, Molecular Functions, and Biological Processes were compared between eligible studies to describe how these dynamic changes transform the myocardium from an injured and inflamed tissue into a scar. Then, we address how cardioprotective interventions distinctly modulate the myocardial transcriptome and discuss the implications of uncovering gene regulatory networks for cardiovascular pathologies and translational applications.
Keywords: RNA-seq; cardioprotection; microarrays; myocardial ischemia; signaling pathways; swine; transcriptomics.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Transcriptomic Hallmarks of Ischemia-Reperfusion Injury.Cells. 2021 Jul 20;10(7):1838. doi: 10.3390/cells10071838. Cells. 2021. PMID: 34360008 Free PMC article.
-
Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.Pharmacol Rev. 2007 Dec;59(4):418-58. doi: 10.1124/pr.107.06002. Epub 2007 Nov 29. Pharmacol Rev. 2007. PMID: 18048761 Review.
-
Inhibition of DRG-TRPV1 upregulation in myocardial ischemia contributes to exogenous cardioprotection.J Mol Cell Cardiol. 2020 Jan;138:175-184. doi: 10.1016/j.yjmcc.2019.12.003. Epub 2019 Dec 10. J Mol Cell Cardiol. 2020. PMID: 31836538
-
Neu3 Sialidase Activates the RISK Cardioprotective Signaling Pathway during Ischemia and Reperfusion Injury (IRI).Int J Mol Sci. 2022 May 29;23(11):6090. doi: 10.3390/ijms23116090. Int J Mol Sci. 2022. PMID: 35682772 Free PMC article.
-
Novel Findings and Therapeutic Targets on Cardioprotection of Ischemia/ Reperfusion Injury in STEMI.Curr Pharm Des. 2019;25(35):3726-3739. doi: 10.2174/1381612825666191105103417. Curr Pharm Des. 2019. PMID: 31692431 Review.
Cited by
-
MiR-130a-3p regulates FUNDC1-mediated mitophagy by targeting GJA1 in myocardial ischemia/reperfusion injury.Cell Death Discov. 2023 Feb 25;9(1):77. doi: 10.1038/s41420-023-01372-7. Cell Death Discov. 2023. PMID: 36841811 Free PMC article.
References
-
- Virani S.S., Alonso A., Aparicio H.J., Benjamin E.J., Bittencourt M.S., Callaway C.W., Carson A.P., Chamberlain A.M., Cheng S., Delling F.N., et al. Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. Circulation. 2021;143:e254–e743. doi: 10.1161/CIR.0000000000000950. - DOI - PubMed
-
- Jennings R.B., Murry C.E., Steenbergen C., Jr., Reimer K.A. Development of cell injury in sustained acute ischemia. Circulation. 1990;82:II2-12. - PubMed
Publication types
LinkOut - more resources
Full Text Sources